The comparative effects of dichloromethylene diphosphonate (C12MDP) and ethane-1-hydroxy-1,1-diphosphonate (EHDP) on growth and modeling of the rat tibia
- PMID: 143335
- DOI: 10.1007/BF02012787
The comparative effects of dichloromethylene diphosphonate (C12MDP) and ethane-1-hydroxy-1,1-diphosphonate (EHDP) on growth and modeling of the rat tibia
Abstract
Male rats weighing 100 g were assigned to groups and injected daily for 10 days with vehicle (control), 0.4, 2.0, 4.0, 10.0, or 20.0 mg/kg/day of ethane-1-hydroxy-1,1-diphosphonate (EHDP) or dichloromethylene diphosphonate (C12MDP). The proximal tibial metaphysis and epiphysis were assayed for changes in percentage of hard tissue and bone formation parameters. From the data, information about hard tissue resorption was deduced. All doses of C12MDP and doses of 2.0 mg EHDP/kg/day and greater caused significant increases in percentage of hard tissues with C12MDP being more effective than similar doses of EHDP in decreasing bone resorption. Osteoclast population parameters were increased with all doses of both C12MDP and EHDP with C12MDP having a greater effect than similar doses of EHDP. Decreases in the proliferation of the osteoprogenitor pool parallel the decreases in osteoblasts and bone formation parameters. These decreases in osteoprogenitor pool proliferation do not account for the increases with diphosphonates in osteoclast population parameters.
Similar articles
-
Ethane-1-hydroxy-1, 1-diphosphonate (EHDP). Effects on growth and modeling of the rat tibia.Calcif Tissue Res. 1975 Sep 5;18(3):215-31. doi: 10.1007/BF02546241. Calcif Tissue Res. 1975. PMID: 810231
-
Ethane-1-hydroxy-1, 1-diphosphonate (EHDP) effects on incorporation and accumulation of osteoclast nuclei.Calcif Tissue Res. 1977 Feb 11;22(3):243-52. doi: 10.1007/BF02010363. Calcif Tissue Res. 1977. PMID: 402991
-
The effect of long-term low-dose diphosphonate treatment on rat bone.Clin Orthop Relat Res. 1982 May;(165):290-9. Clin Orthop Relat Res. 1982. PMID: 6210482
-
Interaction of dichloromethylene diphosphonate and vitamin D on bone of thyroparathyroidectomized rats.Am J Pathol. 1977 Oct;89(1):137-52. Am J Pathol. 1977. PMID: 143891 Free PMC article. Review.
-
Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects.Clin Orthop Relat Res. 1975 May;(108):241-63. doi: 10.1097/00003086-197505000-00038. Clin Orthop Relat Res. 1975. PMID: 166785 Review.
Cited by
-
Fatty acid oxidation in bone tissue and bone cells in culture. Characterization and hormonal influences.Biochem J. 1987 Nov 15;248(1):129-37. doi: 10.1042/bj2480129. Biochem J. 1987. PMID: 3325035 Free PMC article.
-
Influence of a diphosphonate on the cellular aspect of young bone tissue.Calcif Tissue Int. 1980;32(3):247-66. doi: 10.1007/BF02408548. Calcif Tissue Int. 1980. PMID: 6775793
-
Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.Drugs. 1994 Jun;47(6):945-82. doi: 10.2165/00003495-199447060-00007. Drugs. 1994. PMID: 7521833 Review.
-
Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases in bone mass and mechanical properties.Calcif Tissue Int. 1993 Oct;53(4):283-8. doi: 10.1007/BF01320915. Calcif Tissue Int. 1993. PMID: 8275358
-
Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats.Calcif Tissue Int. 1980;32(2):145-57. doi: 10.1007/BF02408534. Calcif Tissue Int. 1980. PMID: 6773632